Salim A Si-Mohamed1, Monica Sigovan1, Jessica C Hsu1, Valérie Tatard-Leitman1, Lara Chalabreysse1, Pratap C Naha1, Thibaut Garrivier1, Riham Dessouky1, Miruna Carnaru1, Loic Boussel1, David P Cormode1, Philippe C Douek1. 1. From the University of Lyon, National Institute of Applied Sciences of Lyon, University Claude Bernard Lyon 1, Jean Monnet University-Saint Etienne, French National Centre for Scientific Research, Institut national de la santé et de la recherche médicale, Centre de Recherche en Acquisition et Traitement de l'Image pour la Santé Unité mixte de recherche 5220, U1206, F-69621, Lyon, France (S.A.S.M., M.S., V.T.L., R.D., L.B., P.C.D.); Departments of Radiology (S.A.S.M., T.G., L.B., P.C.D.) and Pathology (L.C.), Hospices Civils de Lyon, Lyon, France; Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pa (J.C.H., P.C.N., D.P.C.); Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); and Department of Rheumatology, Allergy, and Immunology, Yale University, New Haven, Conn (M.C.).
Abstract
Background Macrophage burden is a major factor in the risk of atherosclerotic plaque rupture, and its evaluation remains challenging with molecular noninvasive imaging approaches. Photon-counting CT (PCCT) with k-edge imaging aims to allow for the specific detection of macrophages using gold nanoparticles. Purpose To perform k-edge imaging in combination with gold nanoparticles to detect and quantify the macrophage burden within the atherosclerotic aortas of rabbits. Materials and Methods Atherosclerotic and control New Zealand white rabbits were imaged before and at several time points up to 2 days after intravenous injection of gold nanoparticles (3.5 mL/kg, 65 mg gold per milliliter). Aortic CT angiography was performed at the end of the follow-up using an intravenous injection of an iodinated contrast material. Gold k-edge and conventional CT images were reconstructed for qualitative and quantitative assessment of the macrophage burden. PCCT imaging results were compared with findings at histologic examination, quantitative histomorphometry, transmission electron microscopy, and quantitative inductively coupled plasma optical emission spectrometry. Pearson correlations between the macrophage area measured in immunostained sections and the concentration of gold and attenuation measured in the corresponding PCCT sections were calculated. Results Seven rabbits with atherosclerosis and four control rabbits without atherosclerosis were analyzed. In atherosclerotic rabbits, calcifications were observed along the aortic wall before injection. At 2 days after injection of gold nanoparticles, only gold k-edge images allowed for the distinction of plaque enhancement within calcifications and for lumen enhancement during angiography. A good correlation was observed between the gold concentration measured within the wall and the macrophage area in 35 plaques (five per rabbit) (r = 0.82; 95% CI: 0.67, 0.91; P < .001), which was higher than that observed on conventional CT images (r = 0.41; 95% CI: 0.09, 0.65; P = .01). Transmission electron microscopy and inductively coupled plasma optical emission spectrometry analyses confirmed the gold k-edge imaging findings. Conclusion Photon-counting CT with gold nanoparticles allowed for the noninvasive evaluation of both molecular and anatomic information in vivo in rabbits with atherosclerotic plaques. Published under a CC BY 4.0 license. Online supplemental material is available for this article. See also the editorial by Leiner in this issue.
Background Macrophage burden is a major factor in the risk of atherosclerotic plaque rupture, and its evaluation remains challenging with molecular noninvasive imaging approaches. Photon-counting CT (PCCT) with k-edge imaging aims to allow for the specific detection of macrophages using gold nanoparticles. Purpose To perform k-edge imaging in combination with gold nanoparticles to detect and quantify the macrophage burden within the atherosclerotic aortas of rabbits. Materials and Methods Atherosclerotic and control New Zealand white rabbits were imaged before and at several time points up to 2 days after intravenous injection of gold nanoparticles (3.5 mL/kg, 65 mg gold per milliliter). Aortic CT angiography was performed at the end of the follow-up using an intravenous injection of an iodinated contrast material. Gold k-edge and conventional CT images were reconstructed for qualitative and quantitative assessment of the macrophage burden. PCCT imaging results were compared with findings at histologic examination, quantitative histomorphometry, transmission electron microscopy, and quantitative inductively coupled plasma optical emission spectrometry. Pearson correlations between the macrophage area measured in immunostained sections and the concentration of gold and attenuation measured in the corresponding PCCT sections were calculated. Results Seven rabbits with atherosclerosis and four control rabbits without atherosclerosis were analyzed. In atherosclerotic rabbits, calcifications were observed along the aortic wall before injection. At 2 days after injection of gold nanoparticles, only gold k-edge images allowed for the distinction of plaque enhancement within calcifications and for lumen enhancement during angiography. A good correlation was observed between the gold concentration measured within the wall and the macrophage area in 35 plaques (five per rabbit) (r = 0.82; 95% CI: 0.67, 0.91; P < .001), which was higher than that observed on conventional CT images (r = 0.41; 95% CI: 0.09, 0.65; P = .01). Transmission electron microscopy and inductively coupled plasma optical emission spectrometry analyses confirmed the gold k-edge imaging findings. Conclusion Photon-counting CT with gold nanoparticles allowed for the noninvasive evaluation of both molecular and anatomic information in vivo in rabbits with atherosclerotic plaques. Published under a CC BY 4.0 license. Online supplemental material is available for this article. See also the editorial by Leiner in this issue.
Photon-counting CT k-edge imaging combined with gold nanoparticles allowed for
the quantitative molecular imaging of macrophages in atherosclerotic plaques
despite calcifications and vascular iodinated enhancement.■ In an animal model, k-edge imaging using photon-counting CT
allowed for the simultaneous imaging of two contrast materials for
evaluation of the atherosclerotic aorta (ie, iodine for lumen and gold
nanoparticles for labeling macrophages).■ The correlation (r = 0.82) between gold
concentration on k-edge images from photon-counting CT and the
macrophage area in the atherosclerotic aorta wall was better than that
using conventional CT (r = 0.41).
Introduction
A therosclerosis is a leading cause of coronary artery disease worldwide,
with a high risk of myocardial infarction as the first major clinical manifestation
(1). Noninvasive imaging of the macrophage
burden, an important determinant of atherosclerotic plaque vulnerability, can assist
in diagnosing patients who are at a high risk of rupture (2,3). CT imaging is a
method of choice for coronary artery disease, and it produces thin-section images of
coronary arteries in less than 1 second (4).
However, current CT technology would be greatly improved by the following:
(a) better spatial resolution, (b) specific
imaging capabilities to differentiate iodine contrast material from wall
calcifications that have a similar attenuation value, and (c) a
specific contrast material to target inflammatory processes in plaques. Recently
developed photon-counting CT (PCCT) may be useful to address these challenges.PCCT uses small detectors to enable high-spatial-resolution imaging (5–8). In addition, these detectors resolve the energy of each photon of the
transmitted spectrum, quantify them, and classify them into energy bins. This
process permits a configurable sampling of the energy-dependent attenuation of a
subject to discriminate between Compton and photoelectric effects that are specific
for a given material (6). In the presence of
one or more exogenous materials with high atomic numbers (ie, 60 or higher), PCCT
enables k-edge imaging to produce quantitative maps of the distribution of an
individual element. This is possible because the system is capable of detecting the
discontinuity of attenuation around the k edge (5,6). Therefore, a k-edge contrast
material that accumulates in macrophages could be extremely advantageous for k-edge
imaging of vulnerable atherosclerotic plaques.Among the candidates for k-edge imaging, promising results have been reported using
gold nanoparticles (9,10). In addition, gold nanoparticles are highly biocompatible,
are extremely dense, and have low viscosity, which is important for in vivo
applications (11). To date, PCCT has shown
encouraging results for cardiovascular imaging in phantoms, animals, and human
studies (7,12–14), including proof of
concept of k-edge imaging for assessing atherosclerotic change (9,15–19).Therefore, we performed PCCT-enabled k-edge imaging in combination with gold
nanoparticles to detect and quantify the macrophage burden within the
atherosclerotic aortas of rabbits. K-edge imaging results were compared with
analyses of conventional CT imaging, findings at histologic examination,
transmission electron microscopy, and quantitative inductively coupled plasma
optical emission spectrometry.
Materials and Methods
Animal Model of Atherosclerotic Plaque
All procedures were conducted with approval from the institutional animal care
and use committee (Comité d’éthique pour
l’expérimentation animale neurosciences Lyon, Autorisation de
projet utilisant des animaux à des fins scientifiques Ministry of
Research no. 1732–2015091411181645) between September 2017 and January
2020. Eleven male New Zealand white rabbits (Charles River Laboratories) were
used. Seven of the 11 rabbits were fed a 1% cholesterol diet (Safe Diets) for 2
weeks before inducing a balloon injury of the aorta, as previously described
(20,21). The same diet was followed for a further 6 weeks then
substituted with a chow diet for 10 weeks. The four uninjured rabbits with
matching weight and sex were fed a regular chow diet and used as
nonatherosclerotic controls.
PCCT Imaging Protocol
Helical acquisitions of the whole rabbit aorta were performed using a PCCT system
(Philips Healthcare) at 120 kVp and 100 mAs, with a pitch of 1 and a rotation
time of 1 second. The PCCT system was a prototype system based on a modified
clinical CT system with a field of view of 160 mm and a z-coverage of 2.5 mm. It
was equipped with energy-sensitive photon-counting detectors of 2-mm-thick
cadmium zinc telluride with a pixel pitch of 270 × 270
µm2 at the isocenter. With respect to k-edge imaging, the
PCCT system allowed for five energy bins set at 30–53, 53–78,
78–83, 83–98, and 98–120 keV for gold imaging only (ie,
monocolor imaging) and gold plus iodine (ie, bicolor imaging) (9,10). In vitro imaging was first performed with tubes containing the
k-edge contrast material (ie, gold nanoparticles), an iodinated contrast
material, and calcium phosphate. In vivo imaging was performed before and after
injection of 3.5 mL/kg of gold nanoparticles (65 mg gold atoms per milliliter of
nanoparticles) at 5 minutes, 45 minutes, 1 day, and 2 days. Aortic CT
angiography was performed at the end of follow-up with 1 mL/kg intravenous
injection of an iodinated vascular contrast material (iomeprol, 400 mg/mL
[Iomeron, Bracco]) at a speed of 2 mL/sec to prove the feasibility of bicolor
imaging in atherosclerosis. The study design is depicted in Figure 1.
Figure 1:
Study design schematic. AuNP = gold nanoparticles, ICP-OES = inductively
coupled plasma optical emission spectrometry, inj. = injection, PCCT =
photon-counting CT, TEM = transmission electron microscopy.
Study design schematic. AuNP = gold nanoparticles, ICP-OES = inductively
coupled plasma optical emission spectrometry, inj. = injection, PCCT =
photon-counting CT, TEM = transmission electron microscopy.
PCCT Image Reconstruction and Analysis
Conventional images in Hounsfield units and spectral images (ie, gold k-edge,
iodine, and water images, scaled in milligrams per milliliter) were
reconstructed from the same acquisition using the same reconstruction parameters
(voxel size, 250 mm3; standard reconstruction kernel). A descriptive
qualitative analysis of the aortic wall in terms of presence of hyperattenuated
regions before and after injection was performed by two observers in consensus
(S.A.S.M., with 10 years of experience, and L.B., with 20 years of experience).
For an analysis of the gold nanoparticle uptake within the aortic wall, we
performed a semiautomatic quantitative analysis of the macrophage burden by
measuring the attenuation on conventional images and the concentration of gold
on gold k-edge images. Analysis was performed by segmenting semiautomatically a
volume of interest of the whole aortic lumen using dedicated software (Amira,
Thermo Fischer Scientific) and a dedicated graphic tablet (Intuos, Wacom). The
masks were then transferred to an in-house Matlab routine (Mathworks) to compute
a wall mask according to a predefined homogeneous thickness (2 pixels, 500
µm thickness). Furthermore, the total quantity of gold within the
segmented wall was calculated according to the mean gold concentration and the
total volume of the mask. For an analysis of gold nanoparticle uptake within the
immunostained aortic wall sections, we performed a quantitative analysis of five
axial sections of 0.25 mm thickness spaced every 5 mm, starting from the first
section below the celiac artery (seven rabbits, 35 sections), that corresponded
to the slices analyzed at histologic examination. The attenuations on
conventional images and gold concentrations on gold k-edge images were measured
by segmenting the wall using the freehand selection tool in ImageJ software
(National Institutes of Health, ) on conventional
images and transferring the region of interest to the corresponding gold k-edge
image (22).
ex Vivo Analyses
For all atherosclerotic rabbits, five sections of the aorta were collected and
analyzed after multiple stainings and imunostaining to score the type of plaque
according to the American Heart Association classification (23), to measure the area of macrophages in
percentage within the wall, to analyze the distribution of gold nanoparticles
with transmission electron microscopy, and to measure the gold content using
quantitative inductively coupled plasma optical emission spectrometry.
Statistical Analysis
Data distributions were tested for normality using the d’Agostino-Pearson
test. Data were expressed as means ± standard deviations and ranges in
Hounsfield units for conventional images, in milligrams per milliliter for gold
k-edge images, and in milligrams for gold quantity measured with inductively
coupled plasma optical emission spectrometry and PCCT.To compare the aortic wall enhancement between time points before injection and 2
days after injection, a two-tailed paired t test was performed
in the atherosclerotic animal group (n = 7) and the control
group (n = 4).To assess the correlation between the macrophage area measured in immunostained
sections and both the concentration of gold and the attenuation measured in the
corresponding PCCT sections (n = 35), a two-tailed Pearson
correlation coefficient was calculated.The nominal level of significance for all tests was P <
.05. Prism software (version 7.0a, GraphPad Software) was used for statistical
analysis.A more detailed description of the methods is given in
Appendix E1 (online).
Results
Seven atherosclerotic New Zealand white rabbits (mean weight, 3.8 kg ± 0.5
[standard deviation]; mean age, 34.5 weeks) and four control nonatherosclerotic New
Zealand white rabbits (mean weight, 3.4 kg ± 0.2; mean age, 18 weeks) were
included. All rabbits completed the study protocol. PCCT images were available for
all animals, with satisfactory image quality at all time points. All data were
analyzed.
in Vitro Characterization and Imaging of the Polyethylene
Glycol–coated Gold Nanoparticles
The gold nanoparticles used had a core size of 12.5 nm as determined with
transmission electron microscopy and a mean hydrodynamic diameter of 18 nm as
determined with dynamic light scattering. Energy-dispersive x-ray spectroscopy
resulted in strong peaks at 2.12, 9.66, and 11.50 keV that are characteristic of
gold atoms (copper and other peaks are background arising from the grid used).
In vitro k-edge imaging depicted only the gold nanoparticle tube, with no
background or signal from the iodine and calcium tubes, confirming the capacity
to detect specifically gold nanoparticles (Fig
2).
Figure 2:
In vitro characterization and imaging of gold nanoparticles (AuNP).
A, Schematic representation of a gold nanoparticle.
B, Transmission electron photomicrograph of gold
nanoparticle. Note that gold nanoparticles are represented by darker
spots. C, Characteristic absorption spectrum of gold at
energy-dispersive x-ray spectroscopy. Au = gold, Cu = copper.
D, In vitro photon-counting CT images of tubes
containing gold nanoparticles (4 mg/mL), iomeprol (4 mg/mL), or calcium
phosphate (1800 HU).
In vitro characterization and imaging of gold nanoparticles (AuNP).
A, Schematic representation of a gold nanoparticle.
B, Transmission electron photomicrograph of gold
nanoparticle. Note that gold nanoparticles are represented by darker
spots. C, Characteristic absorption spectrum of gold at
energy-dispersive x-ray spectroscopy. Au = gold, Cu = copper.
D, In vitro photon-counting CT images of tubes
containing gold nanoparticles (4 mg/mL), iomeprol (4 mg/mL), or calcium
phosphate (1800 HU).
Macrophage Burden Visualization with Gold K-Edge Imaging in Vivo
Before injection of gold nanoparticles, sections with focal hyperattenuation
because of calcifications (Fig 3) on
conventional images were observed along the aortic wall in all atherosclerotic
animals. The location and extent of these sections were variable among the
animals, but they were more predominant within the abdominal aorta, where the
diameter was smaller. No hyperattenuation was observed along the aortic wall in
nonatherosclerotic animals (Fig
E1 [online]).
Figure 3:
Photon-counting CT images of atherosclerotic rabbit aortas before and 2
days after injection (inj.) of gold nanoparticles. A,
Images show noncalcified plaque with strong circumferential enhancement
and mean wall concentration of 4.5 mg/mL of gold nanoparticles. Parietal
calcifications (arrowheads) are also shown. Green line in first image
indicates aortic section analyzed. Rectangles in Overlay Before inj. and
Overlay Day 2 images represent close-up view of parietal wall for better
analyzing enhancement. B, Images show calcified plaque
with strong enhancement within and around calcified area and mean wall
concentration of 2.74 mg/mL of gold nanoparticles. Parietal
calcifications (arrowheads) are also shown. Green line in first image
indicates aortic section analyzed. Spotty areas of enhancement were more
discernable on gold k-edge image than on conventional image. Rectangles
in Overlay Before inj. and Overlay Day 2 images represent a close-up
view of parietal wall for better analyzing enhancement.
C, Box-and-whisker plot shows quantitative analysis
of mean gold concentration found in whole atherosclerotic rabbit
abdominal aortic wall before injection (mean concentration, 0.28 mg/mL
± 0.22; range, 0.01–0.66 mg/mL) and 2 days after injection
(mean, 1.07 mg/mL ± 0.36; range, 0.45–1.56 mg/mL). Lower
and upper margins of each box indicate 25th and 75th percentiles. Cross
represents mean, and line in box represents median. Outliers indicate
minimal and maximal values.
Photon-counting CT images of atherosclerotic rabbit aortas before and 2
days after injection (inj.) of gold nanoparticles. A,
Images show noncalcified plaque with strong circumferential enhancement
and mean wall concentration of 4.5 mg/mL of gold nanoparticles. Parietal
calcifications (arrowheads) are also shown. Green line in first image
indicates aortic section analyzed. Rectangles in Overlay Before inj. and
Overlay Day 2 images represent close-up view of parietal wall for better
analyzing enhancement. B, Images show calcified plaque
with strong enhancement within and around calcified area and mean wall
concentration of 2.74 mg/mL of gold nanoparticles. Parietal
calcifications (arrowheads) are also shown. Green line in first image
indicates aortic section analyzed. Spotty areas of enhancement were more
discernable on gold k-edge image than on conventional image. Rectangles
in Overlay Before inj. and Overlay Day 2 images represent a close-up
view of parietal wall for better analyzing enhancement.
C, Box-and-whisker plot shows quantitative analysis
of mean gold concentration found in whole atherosclerotic rabbit
abdominal aortic wall before injection (mean concentration, 0.28 mg/mL
± 0.22; range, 0.01–0.66 mg/mL) and 2 days after injection
(mean, 1.07 mg/mL ± 0.36; range, 0.45–1.56 mg/mL). Lower
and upper margins of each box indicate 25th and 75th percentiles. Cross
represents mean, and line in box represents median. Outliers indicate
minimal and maximal values.After injection of gold nanoparticles, plaque enhancement and calcifications were
not differentiated on conventional CT images because of similar attenuation
values. The detection of any enhancement within a calcification was not possible
with conventional images, even when making a comparison between pre- and
postinjection images. Uptake of gold nanoparticles was identifiable only on gold
k-edge images. Furthermore, enhancement on gold k-edge images was sometimes
colocalized with calcifications (Fig
3).Aortic wall enhancement in atherosclerotic animals was the highest on
conventional and gold k-edge images at day 2. At this time point,
atherosclerotic aortic walls had extended heterogeneous enhancement in terms of
distribution, either large or punctate, and intensity on conventional and gold
k-edge images. However, punctate enhancements were more easily detected on gold
k-edge images than on conventional images because of the background signal from
the wall itself on conventional images. Conversely, no enhancement was observed
for control nonatherosclerotic aortas (Figs
3–4,
E1–E3 [online]). An illustration of
this molecular k-edge imaging approach in combination with gold nanoparticles in
calcified atherosclerotic plaque is provided in Figure 5.
Figure 4:
Photon-counting CT images of atherosclerotic rabbit aorta before and 2
days after injection (inj.) of gold nanoparticles. A,
Coronal 5-mm-width maximum intensity projection conventional image
before injection shows presence of focal hyperattenuation along aortic
wall indicative of calcifications. B–D, Coronal
5-mm-width maximum intensity projection aortic CT angiograms of
atherosclerotic rabbit injected with vascular contrast material
(iomerprol, 400 mg/mL) at 2 days (D2) after injection of gold
nanoparticles. Lumens of aortic and renal arteries and enhancement of
kidney and dense wall lesions are apparent on, B,
maximum intensity projection conventional and, D,
iodine images. C, Coronal 5-mm-width maximum intensity
projection gold k-edge image shows extensive heterogeneous enhancement
of wall. E, Fusion of three-dimensional (3D) volume
rendering of conventional images with gold k-edge and iodine images
shows spatial distribution of atherosclerotic macrophage burden within
aortic wall. 2D = two-dimensional.
Figure 5:
Molecular k-edge imaging approach using photon-counting CT in vivo for
macrophage detection and quantification in calcified atherosclerotic
plaque in combination with k-edge contrast material of gold
nanoparticles (AuNP). A, Schematic of uptake of gold
nanoparticles by macrophages within atherosclerotic plaque (gold
nanoparticles are shown as yellow dots, macrophages and foam cells are
shown in purple, lipid core is shown in white, and calcification is
shown in red). Gray nodules in foam cells are lipid droplets. White
dashed lines indicate field of view of close-up in B and
C. B, Schematic of conventional CT image
shows different high-attenuation materials (gold nanoparticles and
calcifications) that hamper characterization and quantification of
macrophage burden. C, Schematic of PCCT gold k-edge
image for specific, noninvasive macrophage burden imaging, which permits
quantification of gold nanoparticles.
Photon-counting CT images of atherosclerotic rabbit aorta before and 2
days after injection (inj.) of gold nanoparticles. A,
Coronal 5-mm-width maximum intensity projection conventional image
before injection shows presence of focal hyperattenuation along aortic
wall indicative of calcifications. B–D, Coronal
5-mm-width maximum intensity projection aortic CT angiograms of
atherosclerotic rabbit injected with vascular contrast material
(iomerprol, 400 mg/mL) at 2 days (D2) after injection of gold
nanoparticles. Lumens of aortic and renal arteries and enhancement of
kidney and dense wall lesions are apparent on, B,
maximum intensity projection conventional and, D,
iodine images. C, Coronal 5-mm-width maximum intensity
projection gold k-edge image shows extensive heterogeneous enhancement
of wall. E, Fusion of three-dimensional (3D) volume
rendering of conventional images with gold k-edge and iodine images
shows spatial distribution of atherosclerotic macrophage burden within
aortic wall. 2D = two-dimensional.Molecular k-edge imaging approach using photon-counting CT in vivo for
macrophage detection and quantification in calcified atherosclerotic
plaque in combination with k-edge contrast material of gold
nanoparticles (AuNP). A, Schematic of uptake of gold
nanoparticles by macrophages within atherosclerotic plaque (gold
nanoparticles are shown as yellow dots, macrophages and foam cells are
shown in purple, lipid core is shown in white, and calcification is
shown in red). Gray nodules in foam cells are lipid droplets. White
dashed lines indicate field of view of close-up in B and
C. B, Schematic of conventional CT image
shows different high-attenuation materials (gold nanoparticles and
calcifications) that hamper characterization and quantification of
macrophage burden. C, Schematic of PCCT gold k-edge
image for specific, noninvasive macrophage burden imaging, which permits
quantification of gold nanoparticles.At day 2 after injection of an iodinated vascular contrast material, both
conventional and iodine images showed good enhancement of the lumen with
visualization of an irregular aortic diameter and enlargement of the infrarenal
aorta, which indicates aneurismal development, as well as high-attenuating spots
within the wall. We did not observe any stenosis, thromboses, or ulcerations in
any animal. Conventional and iodine images did not help differentiate between
areas of high-attenuating wall and the enhanced lumen. Only gold k-edge images
depicted specifically the enhancements within the wall. Visual differentiation
between the iodine-enhanced lumen and the gold nanoparticle–enhanced
atherosclerotic macrophage burden was thus possible because of the bicolor
display of PCCT images (Fig 3).
Macrophage Burden Quantification in the Aortic Wall with Gold K-Edge Imaging
in Vivo
For atherosclerotic rabbits, aortic wall enhancement 2 days after injection of
gold nanoparticles on gold k-edge images was higher than that before injection
(mean, 1.07 mg/mL ± 0.36 [range, 0.45–1.56 mg/mL] vs 0.28 mg/mL
± 0.22 [range, 0.01–0.66 mg/mL], respectively; P
= .001) (Fig 3, Table). The same finding was seen with conventional images
(mean, 7 HU ± 15 [range, −7 to 33 HU] vs −11 HU ± 21
[range, −35 to 33 HU]; P = .003). For control rabbits,
no significant increase was measured on gold k-edge images (P
> .05) and conventional images (P > .05).
Atherosclerotic Plaque Characteristics
Atherosclerotic Plaque CharacteristicsFurthermore, the mean gold concentration on gold k-edge images within the
atherosclerotic aortic samples measured with PCCT was 2.73 mg ± 0.92
(range, 1.15–3.98 mg). This high quantity of gold was confirmed with
inductively coupled plasma optical emission spectrometry, with a mean
concentration of gold measured at 1.53 mg ± 0.55 (range, 0.64–2.17
mg).
Macrophage Burden Quantification in Atherosclerotic Plaque with Gold K-Edge
Imaging in Vivo and Correlation with Macrophage Burden at
Immunohistochemistry
Gold concentration was measured 2 days after injection on gold k-edge images in
adjacent sections (seven animals and 35 sections analyzed). The mean gold
concentration was 2.05 mg/mL ± 1.0 (range, 0.13–4.5 mg/mL),
whereas the mean attenuation on conventional images was 70.7 HU ± 23.0
(range, 14.4–138.2 HU). The mean area immunostained for macrophages with
RAM11, or monoclonal anti-rabbit macrophage antibody, on corresponding aorta
sections was 21.5% ± 10.5 (range, 1.0%–47.1%).A good correlation between the gold concentration measured within the wall on
gold k-edge images and the macrophage area was found (Pearson correlation:
r = 0.82; 95% CI: 0.67, 0.91; P <
.001). Conversely, poor correlation was obtained between the attenuation values
measured within the wall on conventional images and the macrophage area
(r = 0.41; 95% CI: 0.09, 0.65; P <
.05) (Fig 6).
Figure 6:
A, B, Photon-counting CT (PCCT) images
of atherosclerotic macrophage burden before injection (inj.) of gold
nanoparticles and 2 days after injection and corresponding
photomicrographs obtained with immunostaining. A,
Images of noncalcified plaque show matches of spotty areas of
enhancement next to mesenteric artery branch. This section is
represented by yellow dot in C and black dot in
D. B, Images of calcified plaque
show low enhancement on gold k-edge image, which is confirmed by low
concentration of immunostained macrophages. This section is represented
by yellow square in C and black square in
D. C, D, Graphs show correlation
between area immunostained for macrophages and, C,
concentration of gold or, D, attenuation on
conventional images. Dotted and dashed lines represent the linear
regression line and 95% CI.
A, B, Photon-counting CT (PCCT) images
of atherosclerotic macrophage burden before injection (inj.) of gold
nanoparticles and 2 days after injection and corresponding
photomicrographs obtained with immunostaining. A,
Images of noncalcified plaque show matches of spotty areas of
enhancement next to mesenteric artery branch. This section is
represented by yellow dot in C and black dot in
D. B, Images of calcified plaque
show low enhancement on gold k-edge image, which is confirmed by low
concentration of immunostained macrophages. This section is represented
by yellow square in C and black square in
D. C, D, Graphs show correlation
between area immunostained for macrophages and, C,
concentration of gold or, D, attenuation on
conventional images. Dotted and dashed lines represent the linear
regression line and 95% CI.Twenty of the 35 plaques (57%) were graded as American Heart Association type IV
(Table). More importantly, 23 of
the 35 plaques (66%) had calcifications. Macrophage foam cells were detected
around lipid cores and also in high-infiltrated fibro-inflammatory cells at the
intima inner surface, as confirmed by immunostaining with RAM11
(Fig
E4 [online]). No macrophage foam cells were
found in the media or the adventitia. In nonatherosclerotic rabbits, the lipid
core, calcification, and layer disorganization were not observable
(Fig
E1 [online]).Transmission electron microscopy confirmed the presence of macrophages and foam
cells in high concentrations around lipid cores as well as the presence of gold
nanoparticles in the plaques of all atherosclerotic rabbits, although gold
nanoparticles were not found in control nonatherosclerotic rabbits. Gold
nanoparticles were distributed in high concentrations intracellularly next to
lipid inclusions, likely because of phagocytosis by the macrophage-derived cells
(Fig
E5 [online]). Note that such deposition was
not observed neither extracellularly in the extracellular matrix nor
intracellularly aside from the foam cells (Fig
E6 [online]).
Discussion
Our results demonstrated specific detection and quantification of macrophage burden
in atherosclerotic rabbits using gold k-edge imaging with a photon-counting CT
system in combination with gold nanoparticles. We also showed the feasibility of
specific differentiation between enhancement of the lumen with one iodinated
contrast material and enhancement of the aortic wall with k-edge gold nanoparticles.
Our results demonstrated the potential for simultaneous assessment of different
diagnostic tasks in atherosclerosis (ie, evaluation of the lumen in terms of
stenosis measurement and thrombus detection and evaluation of the plaque in terms of
composition and vulnerability).In vivo macrophage burden CT imaging has previously been reported with an iodinated
nanoparticle formulation using conventional CT imaging in atherosclerotic rabbits
(24). However, in that study,
calcifications in the aortic wall could not be detected. Indeed, materials with
different chemical compositions can be represented with similar pixel values on
conventional CT images, which means that detection of contrast material uptake in
atherosclerotic plaques can be confounded by the presence of calcifications that are
frequently observed in coronary artery disease (4,25). When using conventional CT
imaging, calcifications will thus interfere with macrophage burden quantification,
which is usually observed in early-stage atherosclerosis (26), and subsequently hinder the assessment of vulnerable
plaque. Even pre-injection imaging with CT would not be satisfactory because of
strong artifacts surrounding the calcifications that could mask small focal
enhancement. Therefore, a need exists for a specific imaging technique, such as PCCT
k-edge imaging, that, as demonstrated by several proof-of-concept studies, has the
capacity to specifically detect and quantify contrast materials (5,9–11,15–17,27,28).An ideal PCCT contrast material for the evaluation of coronary arteries needs to
combine macrophage specificity and a high payload of an element suitable for k-edge
imaging, such as ytterbium, gadolinium, or gold nanoparticles, among others (27–29). Previously, Cormode et al (30) reported that using gold nanoparticles in gold k-edge imaging could
help detect the macrophage burden in an ex vivo mouse model. However, the animal
model and the technical limitations of the system, particularly the low count rate
capability and very long scanning time (approximately 12–24 hours), were
strong limitations for considering feasibility for coronary artery disease imaging.
In our study, using a PCCT prototype system, we demonstrated in vivo that k-edge
imaging is a good imaging technique to visualize the macrophage burden even in the
presence of calcifications, characterize the plaques by demonstrating the presence
of gold nanoparticle uptake in the macrophages, and quantify the macrophage burden
with greater accuracy than conventional CT imaging, thus fulfilling the molecular
imaging expectations (31). Accordingly,
unlike the attenuation of the aortic wall measured on conventional CT images, the
quantity of gold nanoparticles in the aortic wall measured on gold k-edge images
strongly correlated with the macrophage-covered area at immunostaining. Note that
the quantification of a k-edge material has pitfalls as suggested by the nonzero
values of gold concentrations before injection of gold nanoparticles. This is likely
explained by the noise on the photon counts and physical effects, such as beam
hardening, pulse pile-up, and charge sharing, rather than calcium misclassification
(32,33). Indeed, calcium has a k-edge effect (4.0 keV) far from the k edge
of gold (80.7 keV), such that cross talk is avoided. Moreover, calcium k edge is not
measurable because of the absorption of low-energy photons.Two key factors enable the uptake in macrophages. The first is a long circulation
time and penetration into diseased tissue as observed with polyethylene
glycol–coated nanoparticles (11,34), and the second is the high concentration
of macrophages within atherosclerotic plaques (3,21). In our study, these
factors were optimally met 2 days after injection when the specific visualization
and quantification of overall macrophage burden at gold k-edge imaging demonstrated
the uptake of gold nanoparticles by macrophage foam cells in the aortic wall of
atherosclerotic rabbits. This period of time allowed macrophage foam cells to
phagocytize enough material to exceed the current sensitivity of k-edge imaging (ie,
a concentration in the range of milligrams per milliliter, as suggested before for
molecular CT imaging) (9,35). The uptake of the gold nanoparticles by the macrophage
foam cells in the aortic wall was also confirmed by macrophage infiltration in
corresponding histologic sections, gold nanoparticle uptake by macrophage foam cells
at transmission electron microscopy, and gold nanoparticle quantification with
inductively coupled plasma optical emission spectrometry in ex vivo aortas.Another important feature of k-edge imaging is the possibility to perform bicolor
imaging, which is mostly performed with optical imaging techniques (31,36).
Using this feature, we were able to differentiate the atherosclerotic lumen aorta
enlargement labeled with an iodine-based contrast material from the hallmarks of the
inflammatory plaques labeled with gold nanoparticles 2 days after injection.
Therefore, we confirmed that k-edge imaging presents anatomic information of the
lumen and molecular information of the inflammation plaques simultaneously, as
suggested in previous studies (10,30), as opposed to alternative imaging
modalities such as fluorine 18 fluorodeoxyglucose PET (20). Finally, in addition to k-edge imaging, previous studies
have shown that PCCT technology could improve the ability to differentiate
atherosclerotic plaque components (eg, lipids and calcification), based on their
specific photoelectric and Compton effects (30,37,38), the ability to quantify the vasa vasorum density (ie, a
marker of atherosclerotic plaque severity) (39), the visualization of the lumen artery within a stent for diagnosing
in-stent restenosis (12,40), and the quantification and measurement reproducibility of
coronary Agatson calcium score with a low x-ray radiation dose (14). Taken together, these key features make
this modality a promising tool for coronary artery disease imaging and a good
candidate for comprehensive identification of adverse plaque features as identified
by a recent position paper from the European Society of Cardiology (41).Our study had several limitations. Comparative investigation of macrophage burden and
vascular calcifications that are also considered as a marker of vulnerability within
atherosclerotic plaque is lacking (25). The
long-term clearance of gold nanoparticles from atherosclerotic plaque was not
assessed. Finally, the ability to transfer the study’s findings to humans is
unknown because the relationship between gold deposition and plaque rupture was not
evaluated.In conclusion, photon-counting CT–enabled gold k-edge imaging allows for the
specific detection and quantification of the macrophage burden within calcified
atherosclerotic plaques and for simultaneous anatomic and molecular imaging of
atherosclerosis.
Authors: Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner Journal: Circulation Date: 2016-01-26 Impact factor: 29.690
Authors: Salim Si-Mohamed; David P Cormode; Daniel Bar-Ness; Monica Sigovan; Pratap C Naha; Jean-Baptiste Langlois; Lara Chalabreysse; Philippe Coulon; Ira Blevis; Ewald Roessl; Klaus Erhard; Loic Boussel; Philippe Douek Journal: Nanoscale Date: 2017-11-30 Impact factor: 7.790
Authors: Grischa Bratke; Tilman Hickethier; Daniel Bar-Ness; Alexander Christian Bunck; David Maintz; Gregor Pahn; Philippe Coulon; Salim Si-Mohamed; Philippe Douek; Monica Sigovan Journal: Invest Radiol Date: 2020-02 Impact factor: 6.016
Authors: Marc R Dweck; Pál Maurovich-Horvat; Tim Leiner; Bernard Cosyns; Zahi A Fayad; Frank J H Gijsen; Kim Van der Heiden; M Eline Kooi; Akiko Maehara; James E Muller; David E Newby; Jagat Narula; Gianluca Pontone; Evelyn Regar; Patrick W Serruys; Antonius F W van der Steen; Peter H Stone; Johannes L Waltenberger; Chun Yuan; Paul C Evans; Esther Lutgens; Jolanda J Wentzel; Magnus Bäck Journal: Eur Heart J Cardiovasc Imaging Date: 2020-10-20 Impact factor: 6.875
Authors: Jessica C Hsu; Yu Du; Arjun Sengupta; Yuxi C Dong; Katherine J Mossburg; Mathilde Bouché; Andrew D A Maidment; Aalim M Weljie; David P Cormode Journal: ACS Appl Mater Interfaces Date: 2021-11-30 Impact factor: 9.229